Interactive Map Highlights PAD Amputation Hotspots in the U.S.

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

THURSDAY, Sept. 5, 2024 -- A new interactive map has been created by the American Heart Association (AHA) to illustrate the risk for leg, foot, or toe amputations due to peripheral artery disease (PAD) in different regions of the United States.

Mississippi has the highest risk for lower limb amputation, followed by Texas, Louisiana, Alabama, and South Carolina, the Non-Traumatic Lower Extremity Amputations by Congressional District Heat Map shows.

"Increasing knowledge surrounding peripheral artery disease and the potential complication of lower limb amputation is vital, especially considering many people who are at high risk don't even know what PAD is," said investigator Marc Bonaca, M.D., chair of cardiovascular research with the University of Colorado School of Medicine.

Annually, about 150,000 leg amputations occur in the United States due to PAD or other health problems, researchers said.

For the new map, developed by the AHA and other organizations, researchers used 2017 and 2018 data from Medicare and the U.S. Census Bureau to track rates of leg and foot amputations. Rural residents, the poor, and Black and Native American people have the greatest risk for amputation, researchers found.

PAD affects as many as 12 million people in the United States, and Black people are twice as likely to develop the condition, researchers said.

"Much of the amputation data we are seeing is not surprising, yet the map helps us confirm and illustrate what we suspected in terms of where the biggest issues are," Bonaca said in an AHA news release. "When patients with PAD and their health teams advocate for themselves, we can share a firm message that this is a public health issue, and it is preventable."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords